In people with mild cognitive impairment, galantamine, compared to placebo, may make little to no difference in improving memory or the ability to do self-care activities. However, participants who ...

このエビデンスがお役に立ちましたら、コクランへの寄付をご検討ください。私たちは、人々が医療やケアの意思決定をする際に役立つ、利用しやすいエビデンスを作成する慈善団体です。

Tacrolimus, cyclosporin, mycophenolate mofetil, and levamisole may reduce the risk of relapse in children with frequently relapsing nephrotic syndrome. Cyclophosphamide and chlorambucil compared with ...

Using statins for the primary prevention of VTE may slightly reduce the incidence of VTE and all-cause mortality. However, this effect is likely too weak to be considered significant. Statin use may ...

Closing date: 11 November 2024 Cochrane is an international charity. For 30 years we have responded to the challenge of making vast amounts of research evidence useful for informing decisions ...

El tratamiento con MgSO₄ nebulizado podría tener beneficios adicionales modestos para la función pulmonar y el ingreso al hospital cuando se agregan a los agonistas β₂ inhalados y al bromuro de ...

Se identificaron ensayos elegibles mediante búsquedas en MEDLINE, Embase, LILACS, y en la Cochrane Library. Se hicieron búsquedas en los registros de ensayos World Health Organization International ...

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.

このエビデンスがお役に立ちましたら、コクランへの寄付をご検討ください。私たちは、人々が医療やケアの意思決定をする際に役立つ、利用しやすいエビデンスを作成する慈善団体です。

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.

Determinar la eficacia, la seguridad y la tolerabilidad del tapentadol de liberación prolongada para el dolor moderado a grave durante al menos tres meses por cualquier causa musculoesquelética.